The Latest Cannabis Articles from Streetwise Reports

Tilray Shares Climb Higher on Roll Out of New Medical Cannabis Brand Symbios

Tilray Inc. shares traded 11% higher after the company reported the launch of a new medical cannabis brand, Symbios, designed to provide medicinal users with a broader spectrum of formats and cannabinoid potencies at improved price points. read more >

Investor Campbell Becher's Three Core Assets

The former Bay Street investment banker is finding himself going narrower and deeper. read more >

U.S. Cannabis Company 'Cashed Up with Catalysts Materializing'

Research Report
The many reasons why Columbia Care is 'due for a catch-up trade' are discussed in an Echelon Capital Markets report. read more >

A Message from Dr. Copper; Copper Use Is Everywhere

Contributed Opinion
Sector expert Michael Ballanger examines the rise of copper and what that rise means—and portends—for other markets, including the precious metals. read more >

GW Pharmaceuticals Shares Gain 46% on $7.2 Billion Acquisition by Jazz Pharmaceuticals

Shares of GW Pharmaceuticals reached a new 52-week high after the company reported it agreed to be acquired by Jazz Pharmaceuticals in a combination cash and stock deal for $220.00 per share. read more >
Showing Results: 1 to 5 of 5

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe